It is the cache of It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Review of hydroxypropyl cellulose ophthalmic inserts for treatment of
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site


Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye


(5369) Total Article Views

Authors: Nguyen T, Latkany R

Published Date May 2011 Volume 2011:5 Pages 587 - 591

Theresa Nguyen, Robert Latkany
Dry Center, Physician Eyecare of New York, New York, NY, USA

Abstract: Dry eye syndrome is a prevalent disease that affects visual acuity, activities of daily living, and quality of life. A number of contributory factors affect the severity of dry eye syndrome, including autoimmune disease, environmental surroundings, contact lens use, hormonal changes, anatomical features, chronic inflammation, infections, and iatrogenic factors, such as medications or surgery. Symptoms may include intermittent or constant blurry vision, discomfort, burning, foreign body sensation, hyperemia, dryness, and photophobia. The severity of dry eye syndrome can range from very mild disease to extremely severe cases with vision-threatening consequences. A variety of dry eye treatment modalities exist to address the different causes, symptoms, and consequences of ocular surface disease, including artificial tears, lubricating gels, ophthalmic inserts, anti-inflammatory drops, and surgical procedures. In this paper, an assortment of literature pertaining to the treatment of dry eye syndrome, in particular hydroxypropyl cellulose ophthalmic inserts, is reviewed. These inserts can be used effectively as monotherapy, or in conjunction with other therapies, and should be considered in the treatment of dry eye syndrome.

Keywords: hydroxypropyl cellulose ophthalmic inserts, dry eye, punctal occlusion, ocular surface disease

Post to:
Cannotea Citeulike Facebook LinkedIn Twitter

Readers of this article also read: